Early detection of Alzheimer’s disease
Studies performed by Araclon Biotech, have made it possible to quantify the protein Aβ-17 in the blood for the first time. The results show that it is the second most common amyloid beta in the blood (after Aβ-40) and that its levels vary as Alzheimer’s disease progresses. Levels of this protein observed in the blood […]
